The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 1998

Amendment of Schedule 1 to the principal Order

2.  In Schedule 1 to the principal Order (which specifies substances which when included in medicinal products make those products prescription only medicines and exemptions from restrictions on the sale and supply of prescription only medicines)—

(a) in relation to the substance Domperidone Maleate, there are inserted the following entries—

• in column 3

  “For the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn,”

• in column 4

  “10mg (MD)

  40mg (MDD)”

• and in column 5

  “Container or package containing not more than 100mg of Domperidone as Domperidone Maleate;”

  (b)

  in relation to the substance Minoxidil, there are substituted for the entry in column 2 the entries—

  “(1) 2.0 per cent

  (2) 5.0 per cent”

• and for the entry in column 3 the entries—

  “(1) External

  (2) External use for the treatment of alopecia androgenetica, in men aged 18 to 65 (but not in women);”

  (c)

  in relation to the substance Nizatidine—

  (i)

  there are inserted in the entry in column 3, after the word “prevention”, the words “and treatment”, and after the word “heartburn”, the words “and meal-induced indigestion”,

  (ii)

  there is inserted in column 4, after the entry “75mg (MD)”, the entry “150mg (MDD)”, and

  (iii)

  there is substituted in column 4 for the entry “Maximum of 4 such doses in any period of 14 days”, the entry “For a maximum period of 14 days”; and

  (d)

  there is inserted in column 1, at the appropriate point in the alphabetical order of the entries in that column, each of the following substances—

  (i)

  “Pirenzepine Dihydrochloride Monohydrate”

  • “Quinapril Hydrochloride” and

    (ii)

    “Phenolphthalein.”